These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21255693)

  • 41. Histone Deacetylase (HDAC) Inhibitor, Suberoylanilide Hydroxamic Acid (SAHA), Induces Apoptosis in Prostate Cancer Cell Lines via the Akt/FOXO3a Signaling Pathway.
    Shi XY; Ding W; Li TQ; Zhang YX; Zhao SC
    Med Sci Monit; 2017 Dec; 23():5793-5802. PubMed ID: 29211704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ApoE gene deficiency enhances the reduction of bone formation induced by a high-fat diet through the stimulation of p53-mediated apoptosis in osteoblastic cells.
    Hirasawa H; Tanaka S; Sakai A; Tsutsui M; Shimokawa H; Miyata H; Moriwaki S; Niida S; Ito M; Nakamura T
    J Bone Miner Res; 2007 Jul; 22(7):1020-30. PubMed ID: 17388726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells.
    Min A; Im SA; Kim DK; Song SH; Kim HJ; Lee KH; Kim TY; Han SW; Oh DY; Kim TY; O'Connor MJ; Bang YJ
    Breast Cancer Res; 2015 Mar; 17():33. PubMed ID: 25888415
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically.
    Sato A; Asano T; Ito K; Sumitomo M; Asano T
    BJU Int; 2012 Apr; 109(8):1258-68. PubMed ID: 21895936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009.
    Hsieh IN; Liou JP; Lee HY; Lai MJ; Li YH; Yang CR
    Cell Death Dis; 2014 Apr; 5(4):e1166. PubMed ID: 24722291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair.
    Lee JH; Choy ML; Ngo L; Foster SS; Marks PA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14639-44. PubMed ID: 20679231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spontaneous mutation of Dock7 results in lower trabecular bone mass and impaired periosteal expansion in aged female Misty mice.
    Le PT; Bishop KA; Maridas DE; Motyl KJ; Brooks DJ; Nagano K; Baron R; Bouxsein ML; Rosen CJ
    Bone; 2017 Dec; 105():103-114. PubMed ID: 28821457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo.
    Vandyke K; Dewar AL; Diamond P; Fitter S; Schultz CG; Sims NA; Zannettino AC
    J Bone Miner Res; 2010 Aug; 25(8):1759-70. PubMed ID: 20225261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA).
    Hendricks JA; Keliher EJ; Marinelli B; Reiner T; Weissleder R; Mazitschek R
    J Med Chem; 2011 Aug; 54(15):5576-82. PubMed ID: 21721525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.
    Kulp SK; Chen CS; Wang DS; Chen CY; Chen CS
    Clin Cancer Res; 2006 Sep; 12(17):5199-206. PubMed ID: 16951239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis through both mitochondrial and Fas (Cd95) signaling in head and neck squamous carcinoma cells.
    Gillenwater AM; Zhong M; Lotan R
    Mol Cancer Ther; 2007 Nov; 6(11):2967-75. PubMed ID: 18025281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Osteoprotegerin deficiency attenuates strontium-mediated inhibition of osteoclastogenesis and bone resorption.
    Peng S; Liu XS; Zhou G; Li Z; Luk KD; Guo XE; Lu WW
    J Bone Miner Res; 2011 Jun; 26(6):1272-82. PubMed ID: 21611968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of homologous recombination with vorinostat synergistically enhances ganciclovir cytotoxicity.
    Ladd B; Ackroyd JJ; Hicks JK; Canman CE; Flanagan SA; Shewach DS
    DNA Repair (Amst); 2013 Dec; 12(12):1114-21. PubMed ID: 24231389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells.
    Munster PN; Troso-Sandoval T; Rosen N; Rifkind R; Marks PA; Richon VM
    Cancer Res; 2001 Dec; 61(23):8492-7. PubMed ID: 11731433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Positive regulation of osteogenesis by bile acid through FXR.
    Cho SW; An JH; Park H; Yang JY; Choi HJ; Kim SW; Park YJ; Kim SY; Yim M; Baek WY; Kim JE; Shin CS
    J Bone Miner Res; 2013 Oct; 28(10):2109-21. PubMed ID: 23609136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
    Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suberoylanilide hydroxamic acid promotes cardiomyocyte differentiation of rat mesenchymal stem cells.
    Feng C; Zhu J; Zhao L; Lu T; Zhang W; Liu Z; Tian J
    Exp Cell Res; 2009 Oct; 315(17):3044-51. PubMed ID: 19445929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro.
    Wang L; Zhao R; Shi X; Wei T; Halloran BP; Clark DJ; Jacobs CR; Kingery WS
    Bone; 2009 Aug; 45(2):309-20. PubMed ID: 19379851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-Term Hypoxia Accelerates Bone Loss in Ovariectomized Rats by Suppressing Osteoblastogenesis but Enhancing Osteoclastogenesis.
    Wang G; Wang J; Sun D; Xin J; Wang L; Huang D; Wu W; Xian CJ
    Med Sci Monit; 2016 Aug; 22():2962-71. PubMed ID: 27550548
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
    Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
    J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.